A prospective, randomized, multicenter study in patients with an indication for coronary
artery revascularisation who have been accepted for percutaneous coronary intervention (PCI)
of the left main coronary artery. Patients will undergo standard PCI of the left main
coronary artery and will be randomized in a 1:1 fashion to the Synergy stent or to the XIENCE
stent. Dual antiplatelet therapy (DAPT) will be stopped at t=4 months in the Synergy arm
whereas in the control arm DAPT will be continued for 12 months. A subgroup of 100 patients
will have control angiography with Optical Coherence Tomography (OCT) at t=3 months after
treatment.
Phase:
N/A
Details
Lead Sponsor:
NHS National Waiting Times Centre Board
Collaborators:
Boston Scientific Corporation Cardialysis B.V. Diagram B.V. Venn Life Sciences